ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...
TD Cowen analyst Charles Rhyee maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $250.00. The ...
Cencora Enjoys Growth Momentum From GLP-1s, Healthy Utilization Trends, and Growing Specialty Assets
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the firm ...
Shares of Cencora Inc. COR shed 1.12% to $251.57 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 6,037.88 and ...
What are the best co-op games? Games offer up magic in lots of different guises, but working with a friend to achieve a goal is, arguably, where they shine. So what are the titles that will pull ...
A co-signed or joint loan is an option for people who don't qualify for a personal loan on their own. Adding another person’s credit history and income to an application can help you qualify and ...
Cencora COR has outperformed the market over the past 10 years by 6.19% on an annualized basis producing an average annual return of 17.58%. Currently, Cencora has a market capitalization of $49. ...
Cencora, Inc. (NYSE:COR – Get Free Report)’s share price reached a new 52-week high on Monday after JPMorgan Chase & Co. raised their price target on the stock from $289.00 to $301.00.
Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results